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Heterogenous Point Mutations in the Mitochondrial
tRNA Ser(UCN) Precursor Coexisting with the
A1555G Mutation in Deaf Students from Mongolia
To the Editor:
Several mitochondrial mutations have been identified
that exhibit matrilineal transmission of deafness either
in isolation or with other features such as diabetes. The
A1555G substitution in the 12S rRNA gene is known
to be associated with nonsyndromic deafness, with or
without aminoglycoside exposure, in several different
populations (Higashi 1989; Hu et al. 1991; Jaber et al.
1992; Prezant et al. 1993; Pandya et al. 1997; Estivill
et al. 1998). Hamaski et al. (1997) demonstrated specific
binding of aminoglycoside antibiotics to the proposed
1555ArG transition in a mitochondrial 12S rRNA con-
struct, providing evidence in support of the aminogly-
coside-ototoxicity hypothesis suggested by Prezant et al.
(1993). However, the explanation for tissue specificity
and for the pathogenesis in individuals without exposure
to aminoglycosides remains unclear. An additional mu-
tation in a nuclear gene has been postulated as one pos-
sible cause for the latter, but efforts to identify such a
modifier gene have not been successful (Guan et al. 1996;
Bykhovskaya et al. 1998). Another mitochondrial mu-
tation, A7445G, was initially identified, in a Scottish
pedigree, as a cause of sensorineural hearing loss with
incomplete penetrance (Reid et al. 1994; Vernham et al.
1994). In two subsequent pedigrees, from New Zealand
and Japan, a relatively mild palmoplantar keratoderma
(MIM 148350) was also noted in most affected individ-
uals (Sevior et al. 1998). The ArG substitution at po-
sition 7445 changes the final residue of the cytochrome
oxidase (COI) stop codon on the H strand and is also
located immediately adjacent to the 3′ end of tRNA
ser(UCN), whose precursor is encoded on the L strand.
The A7445G mutation was recently shown to retard the
normal processing of the tRNA precursor, resulting in a
70% reduction in tRNA ser(UCN) production and in a
45% decrease in protein synthesis (Guan et al. 1998).
A simultaneous decrease in mRNA for the NADH (ni-
cotinamide adenine dinucleotide [reduced]) dehydroge-
nase (complex I) ND6 subunit may reflect an upstream
effect of the delayed processing of the polycistronic
RNA2 molecule. One or more of these three defects
could contribute to the pathogenesis of deafness (Guan
et al. 1998). In previous work we documented the
A1555G mutation in three Mongolian families with
matrilineal deafness (Pandya et al. 1997). To estimate
the prevalence of both these mitochondrial mutations in
the deaf population in Mongolia, we screened 480 deaf
students and family members ascertained through the
only residential School for Deaf and Blind in Mongolia,
which is located in Ulaanbaatar, as well as 389 Mon-
golian controls with normal hearing. Our sample is es-
timated to include 170% of the student-age deaf pop-
ulation of Mongolia. We identified 37 deaf students with
the A1555G mutation and 9 with the 7445 mutation,
by screening for loss of a restriction site for the Alw26I
and the XbaI restriction enzymes, respectively. Direct
sequencing of DNA from the nine individuals positive
for the loss of an XbaI restriction site revealed hetero-
geneity with novel mutations at one of three adjacent
base pairs—7443, 7444, or 7445. Six students had co-
existent A1555G and G7444A substitutions, which has
not previously been reported.
After informed consent was provided, the clinical his-
tory was obtained and an examination was performed
on each subject by one of the investigators, with special
emphasis on identification of environmental causes of
deafness, such as trauma, meningitis, otitis media, or
pharmacologic ototoxicity, as well as syndromic forms
of genetic deafness. An audiogramwas obtained onmost
deaf individuals, with air conduction being tested at 250,
500, 1,000, 2,000, 3,000, 4,000, 6,000, and 8,000 Hz.
For initial screening, DNA samples were tested for the
presence of A1555G and A7445G mitochondrial mu-
tations, by PCR amplification and subsequent digestion
with Alw26I and XbaI restriction enzymes, as described
elsewhere (Prezant et al. 1993; Reid et al. 1994; Pandya
et al. 1997). The primer pairs used for PCR amplification
were as follows: for the 1555 region, nucleotide (nt)
1261–1282 of the Cambridge sequence (Anderson et
al. 1981) was used for the forward primer, and nt
2866–2843 was used for the reverse primer. For the 7445
region, nt 7178–7198 and nt 7840–7821 were used for
the forward and reverse primers, respectively. The am-
plification products were resolved on a 2% NuSieve gel,
were stained with ethidium bromide, and were photo-
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Figure 1 Representative gel with restriction enzyme digestion
pattern of individuals with the A1555G mutation alone (lanes 4 and
5), with the 7445 mutation alone (lanes 12 and 13), and with both
mutations (lanes 8 and 9). The band pattern for individuals with nor-
mal hearing is depicted for each category with and without digestion
with the appropriate restriction enzyme. The A1555G mutation abol-
ishes a site for the Alw26I enzyme. The undigested PCR product of
1605 bp is digested in normal individuals to yield bands of 1106, 293,
and 206 bp. In affected individuals, lack of digestion results in a larger
band at 1399 bp and in the lower band at 206 bp. The PCR product
obtained with primers for the nt7445mutation is 662 bp. In unaffected
individuals, digestion with the restriction enzyme XbaI results in two
bands—400 and 262 bp in size. The presence of a mutation at this nt
abolishes the recognition sequence for this enzyme with absence of
digestion after incubation with the enzyme.
graphed. On the basis of the restriction analysis, 31 in-
dividuals were found to be positive for the A1555G mu-
tation alone, 3 were positive for the 7445 mutation
alone, and 6 were positive for both (fig. 1).
To confirm the nature of the mutations, sequencing
of DNA samples was performed by means of the Se-
quenase PCR-product sequencing kit from Amersham
Life Science. Approximately 200 ng of the PCR product
was incubated with 10 U of exonuclease 1 and 2 U of
alkaline phosphatase, at 37C for 30 min (Hanke and
Wink 1994), followed by heat inactivation at 80C for
15 min. The appropriate forward or reverse primer was
added to an aliquot of the enzyme-treated PCR product,
followed by the labeling solution mix made up of 40
mM Tris-Hcl (pH 7.5), 20 mM MgCl2, 50 mM NaCl,
5 mM DTT, 0.375 mM 7-deaza dNTP = s, 10 mCi [35S-
a] dATP, and 3.2 U Sequenase. A 4-ml aliquot of this
mixture was transferred to a tube containing 2.5 ml of
the ddNTPs and incubated at 37C for 10 min. The
reaction was stopped with 4 ml of stop dye, and the
samples were denatured and immediately loaded onto a
6% 1# GTG acrylamide sequencing gel. After electro-
phoresis, the gel was dried and placed on an x-ray plate
overnight, before the film was developed. Primers used
to sequence the 1555 region were as described elsewhere
(Pandya et al. 1997). The sequencing primers for the
7445 region were as follows: forward (nt 7321–7341)
and reverse (nt 7623–7600). Ten of the 31 samples that
were positive for the loss of a restriction site at 1555
were sequenced, and all had the A1555G substitution,
as expected (data not shown). In contrast, direct se-
quencing of DNA from the nine individuals with loss of
the XbaI restriction site showed mutational heteroge-
neity, as seen in figure 2. Two of the three individuals
with the isolated loss of the XbaI restriction site had an
A7445C substitution, whereas the third had an A7443G
substitution. All six students with the double mutation
showed a G7444A substitution. This mutation has been
reported elsewhere in association, with Leber hereditary
optic neuropathy (LHON) in whites, but it has been
considered to be a secondary change that may increase
the penetrance of the primary mutation but that is in-
sufficient in itself to cause LHON (Brown et al. 1995).
The G7444A substitution has not been reported in as-
sociation with deafness, however. All the mutations ap-
peared homoplasmic in every affected individual who
tested positive, within the limits of detection by PCR-
RFLP analysis and direct sequencing of PCR products.
No subject with loss of either restriction sitewas detected
among the 389 control samples from hearing Mongo-
lians. Overall, our results indicate an incidence of 7.7%,
0.33%, 0.33%, and 1.33% for the A1555G, A7443G,
A7445C, and A1555G A7444G changes, respectively,
in our population of deaf students.
The six individuals with the G7444A A1555G dou-
ble mutation included five with matrilineal transmission
of hearing loss and one with no family history of deaf-
ness. A definite history of aminoglycoside exposure
could be elicited in only two individuals, but all six had
severe to profound bilateral sensorineural hearing loss
detected at birth or during early infancy. Both individ-
uals with the isolated A7445C mutation had onset of
deafness after an illness at age 1–4 years, and the one
individual with the A7443G mutation had been deaf
since infancy. These findings differ from those reported
for other families with the A7445G mutation, in that
the Scottish family exhibited incomplete penetrance
(Reid et al. 1994) and the New Zealand family had a
late onset (in the second decade) of hearing loss, with
subsequent progression to profound deafness and pal-
moplantar keratoderma (Sevior et al. 1998). The vari-
ability in phenotypic expression noted in these reports
was attributed to differences in the background mito-
chondrial haplotypes of the two pedigrees, thereby im-
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Figure 2 Sense strand sequence of the 3′ region of the tRNA ser(UCN) in a normal individual (A) and in three deaf students (B-D) from
Mongolia. B, A deaf student with the double mutation showing the AGArAAA substitution at nt7444. C, A deaf student with isolated nt 7445
mutation, with substitution of AGArAGC. D, A deaf student with isolated nt 7443 change, with AGArGGA substitution.
plying an interaction between the A7445Gmutation and
a second mitochondrial change. Although a history of
aminoglycoside use was present in two of the six indi-
viduals, it did not appear to be a prerequisite, in view
of the fact that some affected individuals had hearing
loss detected soon after birth. The phenotype of deafness
in individuals with isolated A1555G mutation is quite
variable, with some reported patients developing late-
onset hearing loss in the absence of aminoglycoside ex-
posure (Estivill et al. 1998). These observations raise the
possibility that the coexistence of the twomutationsmay
influence the age at onset and severity of hearing loss,
even in the absence of aminoglycoside exposure. The
sample size is too small to make any definitive conclu-
sions, and further observations would be required to
establish digenic epistasis as a likely explanation for the
apparent phenotypic heterogeneity in these families.
The A7445G mutation is located in the final residue
of the COI gene on the H strand. It alters the normal
stop codon, AGA, to another stop codon, AGG, and
should therefore be a silent change. However, this sub-
stitution has been shown to dramatically alter the pro-
cessing of the tRNA ser(UCN) precursor on the L strand,
as noted previously. It also inhibits the maturation of
other, more distal genes on the L strand, by destabiliz-
ing the major mitochondrial polycistronic transcrip-
tion product, RNA 2 (Guan et al. 1998). All three
newly described substitutions—A7445C, G7444A, and
A7443G—also abolish theXbaI cleavage site at nt 7445.
Since all are also associated with deafness, it seems plau-
sible that they may share with A7445G a common path-
ogenic mechanism, possibly involving interference with
the activity of the endogenous 3′ nuclease, which is re-
quired for normal processing of the tRNA ser(UCN)
precursor. If so, we would predict that these three mu-
tations would act similarly to A7445G and would alter
tRNA ser(UCN) and upstream NADH dehydrogenase
(complex I) ND6 subunit–message maturation, as well
as protein synthesis. An RNASE P–like enzyme and a
tRNA 3′ endonuclease have been implicated as the key
enzymes in the precise cleavage at the 5′ and 3′ ends
of mitochondrial precursor tRNAs (Rossmanith et al.
1995). Although these enzymes have been isolated and
partially purified (Rossmanith 1997; Rossmanith and
Karwan 1998), their number, molecular structure, and
substrate recognition sequences have not yet been well
characterized. On the H strand, however, the three new
mutations we have described would all result in a read-
through of the normal stop codon of the COI message,
leading to the addition of three amino acids to the pro-
tein. The predicted tripeptides additions are SerGlnLys,
LysGlnLys, and ArgGlnLys for the A7445C, G7444A,
and A7443G substitutions, respectively. These changes
are not lethal but could certainly contribute to the ob-
served phenotype by altering the activity of COI either
directly or by modifying the assembly of cytochrome
oxidase (complex IV) holoenzyme. The resulting deficit
in mitochondrial energy transduction may in turn con-
tribute to defective development and function of the au-
ditory sensory tissues. Hence, the potential involvement
of the identified mutations in the synthesis and integrity
of COI and in mitochondrial RNA processing provide
two likely targets for further analysis of the molecular
basis of the phenotype of deafness.
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